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To provide a vehicle for sustained release of cartilage-protective agent for the
potential application of osteoarthritis (OA) treatment, we developed a kartogenin
(KGN)-incorporated thermogel for intra-articular injection. We fabricated a
poly(lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly(lactide-co-glycolide)
(PLGA–PEG–PLGA) thermogel as a KGN carrier for IA injection. OA chondrocytes were
cultured in thermogel with or with no KGN to investigate the effect of KGN thermogel
on cartilage matrix. The in vivo effect of KGN thermogel on OA was examined in a
rabbit OA model. The KGN thermogel showed a sustained in vitro release of KGN for
3 weeks. OA chondrocytes proliferated well both in thermogel and KGN thermogel.
In addition, OA chondrocytes produced higher amount of [type 2 collagen (COL-2)
and glycosaminoglycan (GAG)], as well as lower level of matrix metalloproteinase 13
(MMP-13) in KGN thermogel that those in thermogel with no addition of KGN. The
gene analysis supported that KGN thermogel enhanced expression of hyaline-cartilage
specific genes Col 2 and AGC, and inhibited the expression of MMP-13. Compared with
intra-articular injection of saline or thermogel containing no KGN, KGN thermogel can
enhance cartilage regeneration and inhibit joint inflammation of arthritic knees in a rabbit
ACLT-induced OA model at 3 weeks after the injection. Therefore, the KGN-incorporated
PLGA–PEG–PLGA thermogel may provide a novel treatment modality for OA treatment
with IA injection.
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INTRODUCTION
Osteoarthritis (OA) is a common degenerative joint pathology affecting 151 million people
worldwide. Direct intra-articular injections of drugs are commonly used to improve the joint
bioavailability while minimizing systemic complications. Recently a small molecule, kartogenin
(KGN), has been reported to promote collagen synthesis (Johnson, 2012). Intra-articular injection
of KGN has been reported to enhance cartilage regeneration (Kang et al., 2014; Mohan et al., 2016;
Fan et al., 2018). However, KGN cannot provide long-term therapeutic effects due to fast clearance
and short retention of KGN in joints, posing a disadvantage in its clinical application. In order to
improve residence time of treatment agents in joints, researchers have employed hydrogels for drug
delivery and drug control release (Seliktar, 2012).
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Poly(lactide-co-glycolide)–poly(ethylene glycol)-poly(lactide-
co-glycolide) (PLGA–PEG–PLGA) triblock copolymer has been
used as a potential matrix of thermogel, and can dissolve in
water at low temperature (e.g., 4◦C), and the solution gels
around body temperature (i.e., 37◦C) (Yu et al., 2011; Li
et al., 2012; Wang et al., 2016c, 2019; Zhang et al., 2019).
Given the advantages of possessing and minimally invasive
way of delivering bioactive molecules, in the current study
we used PLGA–PEG–PLGA copolymer to fabricate thermogel
incorporated with therapeutic concentration of KGN for intra-
articular injection. KGN thermogel system was evaluated both
in vitro and in vivo to examine the potential for OA treatment.
We cultured chondrocytes pre-treated with IL-1β to mimic
OA chondrocytes (Cui et al., 2016) in to investigate the effect
of KGN thermogel on OA chondrocytes in terms of cartilage
matrix production and degradation. Then the PLGA–PEG–
PLGA thermogel with or without KGN was injected in to OA
knees in rabbits to examine the effects of KGN thermogel on OA.
MATERIALS AND METHODS
PLGA–PEG–PLGA Thermogel Preparation
PLGA–PEG–PLGA triblock copolymers were purchased from
(Daigang Co., Ltd., Jinan, Shandong, China). The copolymers
were synthesized through the ring-opening polymerization
(ROP) of L-LA and GA with PEG as a macroinitiator and
Sn(Oct)2 as a catalyst as previously reported (Wang et al.,
2016c). The Mns of PEG and PLGA were 1,500 and 1,400 g/mol,
respectively. The molar ratio of L-LA and GA in PLGA segment
is 75:25. PLGA–PEG–PLGA triblock copolymers was dissolved
in PBS (pH 7.4) to obtain a 20 wt% gel solution, which was then
kept at 4◦C before being used in the following experiments. The
sol—gel transition behavior of PLGA-PEG-PLGA thermogel was
confirmed by incubation at 37◦C for 15 min.
Preparation of KGN Thermogel
Ten milligrams of KGN (Selleck Chemicals, Shanghai, China)
was dissolved in 0.6ml dimethyl sulfoxide (DMSO) and then
diluted with PBS (pH 7.4) to obtain 5mM KGN working
solutions. KGN thermogel was prepared by mixing 100 µl 5mM
KGN solution with 10ml PLGA-PEG-PLGA gel solution to
obtain KGN gel solution containing 50µM KGN. PLGA-PEG-
PLGA gel solution without KGN was used as control.
In vitro KGN Release
The in vitro sustained release of KGN from the KGN thermogel
was determined by an ultra-micro UV spectrophotometer
(Nanodrop 2000). Briefly, 1mL of 20 wt% thermogel or KGN
thermogel solution was placed in a vial of a 16mm inner diameter
for gelation at 37◦C. Then 2mL PBS was added on top of the
gel. The supernatant was collected at set time intervals (0.0, 1.0,
3.0, 7.0, 11.0, 15.0, and 20.0 days). Another 2ml PBS was then
replaced. Serial concentrations of KGN in PBS solution were used
as standards. The measurement was carried out with a detection
wavelength of 277 nm. The amount of released KGN at each time
point was calculated as percentage of the total KGN content of a
1mL 20 wt% thermogel or KGN thermogel solution.
Isolation and Culture of Chondrocytes
Two-month-old adult New Zealand White rabbits weighing
around 1.5 kg were sacrificed for isolation of chondrocytes
as previously mentioned (Wang et al., 2016a). Primary
chondrocytes were harvested from the cartilage of knees and
shoulders. First, the minced cartilage was digested for 6 h in
10mL of 0.2% w/v collagenase type 2 (Gibco BRL Co. Ltd.)
solutions at 37◦C. The resultant cell suspension was centrifuged
and resuspended in low-glucose DMEM supplemented with
10% FBS (HyCloneTM, Thermo Scientific, Australia) and 1%
penicillin and streptomycin. Isolated chondrocytes were cultured
in monolayer cultures in a humidified incubator at 37◦C, 5%
CO2, and 21% O2. Passage 2 chondrocytes were utilized for
subsequent experiment.
Chondrocytes Treated With IL-1β
Passage 2 adherent rabbit chondrocytes reaching 60–70%
confluency was cultured with serum-starved medium
(DMEM/F12 supplemented with 1% FBS) for 12 h, and
then was treated with IL-1β (10 ng/ml) for 2 h for the following
in vitro experiments.
Design of Rabbit Knee OA Model
This study was carried out in accordance with the Guide for the
Care and Use of Laboratory Animals of the National Institutes
of Health. The protocol was approved by the Committee on
the Ethics of Animal Experiments of Xiamen University. The
anterior cruciate ligament transection (ACLT) procedure was
performed to induce knee OA model as previously reported (Liu
et al., 2016). New Zealand white rabbits (n = 24, age 5 months,
weight 2.5–3.0 kg) were then divided into two groups (sham
and ACLT). After anesthesia and routine preparation, 18 rabbits
were performed ACLT on the left knees and six rabbits were
performed a sham surgery. At 3 weeks after ACLT, rabbits were
randomly divided into three groups (six rabbits in each group) for
intra-articular injection of saline, thermogel, or KGN thermogel.
At 6 weeks after the sham surgery or 3 weeks after the intra-
articular injection, the left knees in every group were harvested
for histological analysis, and synovial fluid was collected for
analysis of interleukin-1 (IL-6) and MMP-13, to evaluate the
inflammation of knees.
In vitro Culture of IL-1β Treated
Chondrocytes in KGN Thermogel
The cell suspension containing 5.0 × 105 IL-1β treated
chondrocytes was mixed with 100.0 µL of thermogel or KGN
thermogel solution at 4◦C and then transferred into a 24-
well plate. The mixed cells–copolymer solution was incubated
at 37◦C for 15min for gelation and cell initial attachment.
2.0mL of fresh DMEM supplemented with 10% (V/V) FBS
(HyCloneTM, Thermo Scientific, Australia), and 1% penicillin
and streptomycin (Invitrogen, Carlsbad, CA, USA) was added.
For cell proliferation assay and DNA content analysis, the
cells-laden thermogel was cultured for 1 week in DMEM. The
culture medium was changed every 2 days. The proliferation
activity of cells was measured at day 1, 5, and 7 using
a Cell Counting Kit-8 assay (CCK-8; Dojindo Laboratories,
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Kumamoto, Japan) according to the manufacturers’ instructions.
Briefly, cell culture (n= 3) were gently rinsed with PBS and then
submerged in a mixed solution of 10.0 µL of CCK-8 reagent with
90.0µL of freshmedium at 37◦C for 2 h. The absorbance readings
at 450 nm were observed using a plate reader.
Biochemical Analysis
To reveal the effect of KGN thermogel on OA chondrocytes,
we measured the matrix degradation enzyme (MMP-13),
extracellular matrix component [type 2 collagen (COL-2) and
glycosaminoglycan (GAG)] secreted from OA chondrocytes.
Briefly, the specimens were digested in a pre-prepared papain
solution containing 0.5M EDTA, 0.05M cysteine hydrochloride,
and 1.0 mg/mL papain enzyme (Sigma, St. Louis, MO, USA)
at 60◦C for 12 h. The aliquots of the sample digestion were
used for the measurements of DNA and GAG, as previously
reported (Wang et al., 2016a). DNA content was measured using
a fluorescence assay. Total glycosaminoglycan (GAG) content
was determined using a 1,9-dimethylmethylene blue (DMMB;
Sigma, St. Louis, MO, USA) dye-binding assay. The culture
medium of IL-1β treated chondrocytes was collected after 3 weeks
of culture in KGN thermogel. Supernatant was separated from
insoluble residues by centrifugation at 12,000 rpm for 10min.
Rabbit MMP-13 and COL-2 ELISA Kits (Cloud-Clone, Corp.,
Houston, TX, USA) were used to measure the COL-2 and MMP-
13 according to the manufacturer’s instructions. GAG, COL-2,
and MMP-13 concentrations were normalized to DNA content
which was determined fluorometrically using Hoechst staining
as previously described (Wang et al., 2016a).
Gene Expression Analyses
To evaluate the effect of KGN on OA chondrocytes, we measured
the expressions of arthritis -related genes and cartilage-related
genes. Gene expressions were detected by real-time polymerase
chain reaction (RT-PCR) as previously reported (Wang et al.,
2016a). At predesignated time points, samples (n = 3) were
homogenized in Trizol Reagent (Invitrogen, Carlsbad, CA, USA)
with a tissue grinder and RNA was extracted according to
the manufacturer’s instructions. Isolated RNA concentration
was determined by an ND-2000 spectrophotometer (Nanodrop
Technologies). One microgram of RNA from each sample
was reverse transcribed into cDNA using the MMLV Reverse
kit (Promega, Madison, WI, USA), and RT-PCR analysis was
performed using ABI 7300 real-time PCR system (Applied
Biosystems, Foster City, CA, USA) with SYBR Green PCR
Master Mix (Toyobo, Osaka, Japan). The relative gene expression
was expressed by fold difference which was calculated as
211CT. The relative expression changes in these target genes
were quantified by normalizing their expression to that of
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). PCR primers for: type 1 collagen (COL-1), type 2
collagen (COL-2), aggrecan (AGC), MMP-13, and GAPDH were
listed in Table 1.
Histological Analysis
After intra-articular injection for 3 weeks, each group of rabbits
was euthanatized with overdose of pentobarbital sodium. Distal
TABLE 1 | Primer sequences used for real-time PCR.
Gene Forward primers (5′-3′) Reverse primers (5′-3′)
COL-1 TGGCAAGAACGGAGATGACG GCACCATCCAAACCACTGAA
COL-2 CCACGCTCAAGTCCCTCAAC AGTCACCGCTCTTCCACTCG
AGC CGTGGTCTGGACAGGTGCTA GGTTGGGGTAGAGGTAGACG
MMP-13 TTGACCACTCCAAGGACCCAG GAGGATGCAGACGCCAGAAGA
GAPDH CCATCACCATCTTCCAGGAG GATGATGACCCTTTTGGCTC
Col-1, type 1 collagen; Col-2, type 2 collagen; AGC, aggrecan; MMP-13, matrix
metalloproteinase 13; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
femur was resected for histological evaluation. No joint infection
occurred in all knees. To evaluate the inflammation of knee
joints, synovial fluid was collected for analysis of interleukin-6
(IL-6) and MMP-13. After dissection and fixation, the samples
were decalcified in 15% EDTA (pH 7.2 in PBS) with 5%
paraformaldehyde at 4◦C. The decalcified medial condyles were
then trimmed, dehydrated in a graded ethanol series and
embedded in paraffin. Sections were stained with H&E, TB
(positive for proteoglycans) and immunohistochemical (IHC)
staining (positive for COL-2). The protocols for detection
of COL-2 were described in above sections. The histological
sections were blindly reviewed for quantitative evaluation of the
cartilage destruction using the Osteoarthritis Research Society
International (OARSI) scoring system (Pritzker et al., 2006).
Statistical Analysis
All data were expressed as means ± standard deviation and
represented at least three independent experiments. All data
were analyzed using a two-way ANOVA test. P < 0.05 were
considered significant. When ANOVA results were significant,
post-hoc analysis was performed via Tukey’s multiple comparison
test. All analyses were carried out using GraphPad Prism version
6.0 for Windows (GraphPad Software, San Diego, CA).
RESULTS
In vitro Assessments of KGN Release
The PLGA–PEG–PLGA copolymer in PBS (20 wt%) with or
without KGN showed stable gelation at 37◦C. The sustainably
release KGN in vitro from the KGN thermogel determined
whether the functionalized thermogel can produce sufficiently
chondrogenic effects (commonly used concentration is 100
nM−10µM in vitro and 10 µM−100µM in vivo). The KGN
concentration in the 20 wt% polymer solution was about 50µM.
Therefore, the KGN thermogel showed an abrupt release (20%)
of KGN at day 1 (10µM), followed by a sustained release (about
3% per day) of KGN per day (1.5µM /day), as shown in Figure 1.
Cell Viability and Proliferation
After culture in growth medium for 72 h, CCK assay showed
that OA chondrocytes proliferated in both PLGA-PEG-
PLGA thermogel and KGN thermogel showed an increased
proliferation during 7 days of in vitro culture (Figure 2A).
However, the number of OA chondrocytes in thermogel and
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KGN thermogel on Day 7 did not differ significantly, compared
to that on Day 1 (p > 0.05). Notably, the number of MSCs in
KGN thermogel slightly surpassed that in the thermogel.
Extracellular Matrix Related Component
Production
GAG and COL-2 content were detected to quantify cartilaginous
matrix production by OA chondrocytes. Increased amount of
GAG and COL-2 from OA chondrocytes were found after
culture in thermogel or KGN thermogel for 14 days (Figure 2B).
Significantly higher amount of GAG and COL-2 was detected in
KGN thermogel than that in thermogel group (p < 0.05). On the
other hand, increased secretion of MMP-13 was only found in
thermogel, whereas minimal increase of MMP-13 was detected
in KGN thermogel. These results showed that KGN enhanced the
production of COL-2 and GAG and inhibited the production of
FIGURE 1 | In vitro sustained KGN release from KGN thermogel (20.0 wt%) in
PBS (pH 7.4) at 37◦C (n = 3).
MMP-13 from OA chondrocytes, suggesting that KGN played an
anti-arthritic role in OA chondrocyte-laden thermogel.
Cartilage-Specific Gene Expression
Analyses
To compare the chondro-protective capacity of KGN thermogel,
we measured gene expressions of COL-1, COL-2, AGC, and
MMP-13. Significant differences of gene expression were found
between thermogel group and KGN thermogel group at both 14
and 21 days of in vitro culture (Figure 3). Greater upregulation
of hyaline-cartilage specific genes COL-2 and AGCwere detected
in KGN thermogel system that that in thermogel with no KGN
(p < 0.05). However, the expression of fibrocartilage-related
marker COL-1 was similar between the two groups. In addition,
the MMP-13 expression was reduced in KGN thermogel group
suggesting KGN could inhibit matrix degradation.
In vivo Cartilage Regeneration
The histological staining showed that the OA model was
successfully established in rabbit knees at 3 weeks after ACLT.
Obvious OA changes of cartilage occurred at 6 weeks after ACLT
in OA group, OA + Gel group, and OA + KGN gel group,
with cartilage fibrillation, surface erosion, fissure, denudation,
and deformation (Figure 4). Slight cartilage degeneration was
observed in sham group with chondrocyte hypertrophy and
clustering. Importantly, we noted a distinct chondroprotective
effect of KGN thermogel in OA+ KGN gel group which showed
shallow vertical fissures of the superficial cartilage, localized
proteoglycan depletion, and partial COL-2 loss in limited zones
of the cartilage. In comparison, both OA and OA+ thermogel
groups showed severe OA changes, with significant cartilage
denudation and deformation, as well as marked proteoglycan
and COL-2 depletion. These data suggested that IA injection of
KGN showed an anti-inflammatory effect and promoted cartilage
regeneration, as compared to IA injection of saline or thermogel.
OA knees treated with KGN thermogel injection
demonstrated delayed cartilage degeneration and low
level of articular inflammation, as indicated by IL-6 and
MMP-13 content. In contrast, the IL-6 and MMP-13 levels
FIGURE 2 | In vitro cell proliferation and matrix component production. (A) CCK-8 assay showed that the proliferation of IL-1β treated chondrocytes in thermogel or
KGN thermogel increased over time (B) GAG content was measured by DMMB assay, COL-2, and MMP-13 were determined by ELISA after IL-1β treated
chondrocytes were cultured in thermogel or KGN thermogel for 2 weeks (n = 3, *P < 0.05).
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FIGURE 3 | Expression of cartilage-related genes of COL-2 and AGC, COL-1, and MMP-13 of OA chondrocytes within thermogel with or without KGN (n = 3;
*p < 0.05).
FIGURE 4 | Histological staining of OA knee treated with saline (OA), thermogel (OA + Gel), and KGN thermogel (OA + KGN gel) at 6 weeks after ACLT surgery.
(A–D) H&E, (E–H) toluidine blue (TB), and (I–L) immunohistochemistry (IHC) COL-2 staining.
were significantly higher in OA and OA + Gel groups
(p < 0.01; Figure 5).
The OARSI scores grade histopathology of OA based on
extent of joint involvement and the depth of lesion (Pritzker et al.,
2006). As shown in Figure 6, OARSI scores were significantly
lower in sham group and OA + KGN group that those of OA
and OA + Gel groups (p < 0.001). The OA group treated with
saline IA injection displayed progressive cartilage degeneration
with extensive and deep involvement of cartilage. The OARSI
scores revealed no significant differences between OA gel group
and OA group (p > 0.05). These data suggested ongoing arthritis
and cartilage destruction in OA group and OA + Gel group,
and subsided arthritis and regenerated cartilage in arthritic knees
treated with KGN thermogel.
DISCUSSION
OA is characterized by extracellular matrix (ECM) degradation
and cell loss. The main components of ECM in cartilage are
proteoglycans and collagens, and the loss of AGC and COL-2 in
ECM leads to cartilage degradation. Matrix metalloproteinases
(MMPs), for example, MMP-13, have been shown to directly
cleave collagens and aggrecan (Zhao et al., 2014).
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FIGURE 5 | ELISA method detecting IL-6 and MMP-13 content in synovial fluid of all groups at 6 weeks (n = 8, *p < 0.05, **p < 0.01).
FIGURE 6 | OARSI scores were significantly lower in Sham group and OA +
KGN gel group that those of OA and OA + Gel groups (**p < 0.01,
***p < 0.001).
The close articular cavity allows the possibility of IA drug
administration for OA patients. IA injection of drugs will avoid
or minimize side effects of systematically administered drugs,
such as toxicity and gastrointestinal complications (He et al.,
2017). However, the low retention time limits the application
of IA injection. Hydrogels are physically or chemically cross-
linked three-dimensional polymers swollen in water that allows
the controlled release of bioactive agents (Park et al., 2009) and
possesses the capacity of maintaining chondrocyte phenotype
(Chung and Burdick, 2008; Spiller et al., 2011; Liu et al., 2018).
Among various hydrogels, the thermo-sensitive hydrogel from
PLGA–PEG–PLGA copolymer has been especially attractive,
as their spontaneous gelation under physiological conditions
presents some advantages: minimal invasive wounds, efficiency
of cell encapsulation and controlled release of bioactivemolecules
(Zhang et al., 2014, 2015; Li et al., 2016).
In the current work, the cartilage-protective molecule KGN
was incorporated into the PLGA–PEG–PLGA thermogel with
the capacity of sustained release of KGN for as long as 3
weeks. We used IL-1β treated rabbit chondrocytes to investigate
the effect of KGN on OA chondrocytes. In vitro experiment
showed that KGN thermogel was compatible with cell survival,
however with no capacity to promote proliferation of OA
chondrocytes. In addition, when cultured in KGN thermogel,
OA chondrocytes produced higher amount of GAG and COL-
2 than those in thermogel without addition of KGN. These data
are consistent with others which showed that KGN promoted
cartilage regeneration and induced chondrogenic differentiation
of mesenchymal stem cells (Kang et al., 2014, 2016; Wang et al.,
2016b; Fan et al., 2018; Han et al., 2019). In addition, the level of
MMP-13 produced by OA chondrocytes in KGN thermogel was
much less compared to that in thermogel. This is consistent to
the increased amount of COL-2 and GAG, which can be directly
degraded by MMP-13. Therefore, KGN thermogel system
have showed biocompatibility and cartilage-protectiveness. The
gene analysis was in line with the above ELISA results, as
KGN thermogel group enhanced expression of hyaline-cartilage
specific genes COL-2 and AGC, and inhibited the expression
of MMP-13. This result is again supported by other researchers
(Wang et al., 2015; He et al., 2017; Patel et al., 2019).
To confirmed the feasibility of using KGN thermogel for
the treatment of OA, we established knee OA model using
ACLT procedure. The OA knees treated with KGN thermogel
yielded significantly greater cartilage regeneration and less joint
inflammation, as suggested by histological staining, OARSI score
and synovial fluid analysis of inflammatory cytokines. These in
vivo data strongly indicated that KGN played an anti-arthritic
and chondro-protective role in arthritis.
Some limitations remain in the present study. Firstly, the
current study is only a preliminary study for the effect of KGN
on the early stage OA. However, more time points for IA
injection at different OA stages will add more clarification for
the effect of KGN on OA treatment. Secondly, the potential
molecular mechanism regarding the effect of KGN on OA was
not revealed in the current study. Further studies about KGN
in anti-inflammation or redifferentiation of OA chondrocytes
should be needed in the future.
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In summary, we have shown that KGN thermogel can
release KGN both in vitro and in vitro. IA injection of
KGN thermogel can enhance cartilage regeneration and inhibit
joint inflammation in OA knees in a rabbit model. KGN
thermogel protects the cartilage by promoting OA chondrocytes
to produce COL-2 and GAG, while reducing the secretion
of MMP-13.
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